Teladoc Health, Inc. reported its financial results for the third quarter of 2024 on October 30, 2024. The company experienced a 3% decrease in revenue year-over-year, totaling $640.5 million, and a net loss of $33.3 million, or $0.19 per share. Adjusted EBITDA also saw a decline of 6% to $83.3 million. Despite the downturn, the Integrated Care segment saw a revenue increase of 2% to $383.7 million and an improved adjusted EBITDA margin of 17.7%. Conversely, the BetterHelp segment's revenue fell by 10% to $256.8 million, with an adjusted EBITDA margin of 5.9%. CEO Chuck Divita expressed commitment to execution and potential for growth, indicating that 2025 will be a pivotal year for repositioning. The company's U.S. revenue decreased by 6%, while International revenue grew by 15%. A significant non-cash goodwill impairment...Show More

Teladoc Health, Inc. reported its financial results for the third quarter of 2024 on October 30, 2024. The company experienced a 3% decrease in revenue year-over-year, totaling $640.5 million, and a net loss of $33.3 million, or $0.19 per share. Adjusted EBITDA also saw a decline of 6% to $83.3 million. Despite the downturn, the Integrated Care segment saw a revenue increase of 2% to $383.7 million and an improved adjusted EBITDA margin of 17.7%. Conversely, the BetterHelp segment's revenue fell by 10% to $256.8 million, with an adjusted EBITDA margin of 5.9%. CEO Chuck Divita expressed commitment to execution and potential for growth, indicating that 2025 will be a pivotal year for repositioning. The company's U.S. revenue decreased by 6%, while International revenue grew by 15%. A significant non-cash goodwill impairment charge of $790 million was recorded, attributed to the BetterHelp segment, which did not impact the provision for income taxes. The company's cash flow from operations increased slightly in the third quarter to $110.2 million, and free cash flow improved to $79 million. Teladoc Health provided a financial outlook for the Integrated Care segment, expecting a revenue growth percentage of 0% to 2.5% for the fourth quarter and a low to mid-single-digit growth for the full year of 2024.